, Singapore

Daily Markets Briefing: STI down 0.34%

Expect little gains today.

The Straits Times Index ended 10.41 or 0.34% lower at 3,043.19.

The top active stocks were DBS, which fell 0.12%, OCBC, which slipped 0.08%, Cordlife, which rose 0.06%, Best World, which grew 0.10%, and UOB, with a 0.10% fall.

The FTSE Mid Cap dipped 0.38% whilst the FTSE Small Cap slipped 4.72%.

According to OCBC Investment Research, U.S. stocks closed lower Wednesday, with the Dow Jones Industrial Average logging its longest losing streak in three months, as blue-chip Apple Inc. flirted with bear-market territory.

Nine out of eleven S&P 500 industries ended lower, led by Financials (-1.38%) and Information Technology (-1.29%) whilst Communication Services (0.46%) and Real Estate (0.06%) gained.

"The retreat on Wall Street overnight is unlikely to bring any inspiration to the local bourse this morning," OIR said.

Join Singapore Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

DBS and OCBC expected to deliver steady Q1 net profits
Their net interest margins will ease as a result of their Hong Kong loans.
Singapore's maritime cluster navigates towards digital, green future
Adapting to emerging challenges, such as the adoption of alternative fuels, is deemed crucial for the country's maritime sector.
Shipping & Marine
SCG and A*STAR unveil joint labs for cellular immunotherapy enhancement
The partnership has a funding of nearly $30m supported under Singapore's Research, Innovation and Enterprise 2025 plan.
Healthcare